Unlocking the Future of Neuromodulation: Trends, Strategy, & Market Growth Analysis
Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. The neuromodulation market is driven by the increasing incidences of neurological diseases such as Alzheimer’s disease, Parkinson’s...
Neuromodulation Market Forecast: Growth to USD 11.0 Billion by 2028
The global neuromodulation market is projected to reach USD 11.0 billion by 2028 from USD 6.2 billion in 2023, at a CAGR of 12.0% during the forecast period. The neuromodulation market is driven by increasing focus on the development of advanced neuromodulation and neurostimulation technologies, rising prevalence of neurological disorders and nerve injuries, government support for research on...
Growth and Demand of Neuromodulation Market in APAC Region
The growth of neuromodulation market is driven majorly by
the rising prevalence of neurological disorders, increasing research into
expanding the applications of neuromodulation, and awareness on
neurodegenerative disorders. However, the high cost of neuromodulation
procedures and equipment, along with the dearth of a trained workforce, is
expected to restrain the growth of this market during the...
Neuromodulation: Research Into Expanding the Applications of Neuromodulation
Which are The Key Factors Driving Growth and Demand of
Neuromodulation Industry?
The growth of neuromodulation market is driven majorly by the rising
prevalence of neurological disorders, increasing research into expanding the
applications of neuromodulation, and awareness on neurodegenerative disorders.
However, the high cost of neuromodulation procedures and equipment, along with
the dearth of...
Neuromodulation Market: What kind of growth is expected in the market?
The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target...